ECSP099506A - DERIVATIVES OF 2-QUINOLINONA AND 2 QUINOXALINONA AND ITS USE AS ANTI BACTERIAL AGENTS - Google Patents

DERIVATIVES OF 2-QUINOLINONA AND 2 QUINOXALINONA AND ITS USE AS ANTI BACTERIAL AGENTS

Info

Publication number
ECSP099506A
ECSP099506A EC2009009506A ECSP099506A ECSP099506A EC SP099506 A ECSP099506 A EC SP099506A EC 2009009506 A EC2009009506 A EC 2009009506A EC SP099506 A ECSP099506 A EC SP099506A EC SP099506 A ECSP099506 A EC SP099506A
Authority
EC
Ecuador
Prior art keywords
quinoxalinona
quinolinona
derivatives
bacterial agents
anti bacterial
Prior art date
Application number
EC2009009506A
Other languages
Spanish (es)
Inventor
Folkert Reck
Janelle Comita-Prevoir
Mark Cronin
Bolin Geng
Andrew Aydon Godfrey
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39046831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP099506(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ECSP099506A publication Critical patent/ECSP099506A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención se refiere a compuestos de Fórmula (I): y sales farmacéuticamente aceptables de los mismos, a su uso en el tratamiento de infecciones bacterianas y a sus métodos de preparación.The present invention relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, their use in the treatment of bacterial infections and their methods of preparation.

EC2009009506A 2006-12-15 2009-07-09 DERIVATIVES OF 2-QUINOLINONA AND 2 QUINOXALINONA AND ITS USE AS ANTI BACTERIAL AGENTS ECSP099506A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87018106P 2006-12-15 2006-12-15
US96916307P 2007-08-30 2007-08-30

Publications (1)

Publication Number Publication Date
ECSP099506A true ECSP099506A (en) 2009-08-28

Family

ID=39046831

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009506A ECSP099506A (en) 2006-12-15 2009-07-09 DERIVATIVES OF 2-QUINOLINONA AND 2 QUINOXALINONA AND ITS USE AS ANTI BACTERIAL AGENTS

Country Status (17)

Country Link
EP (1) EP2121702A1 (en)
JP (1) JP2010513255A (en)
KR (1) KR20090090385A (en)
AR (1) AR064369A1 (en)
AU (1) AU2007331247B2 (en)
BR (1) BRPI0720236A2 (en)
CA (1) CA2671485A1 (en)
CL (1) CL2007003641A1 (en)
CO (1) CO6190619A2 (en)
EC (1) ECSP099506A (en)
MX (1) MX2009006325A (en)
NO (1) NO20092655L (en)
PE (1) PE20081511A1 (en)
RU (1) RU2009126731A (en)
TW (1) TW200831517A (en)
UY (1) UY30788A1 (en)
WO (1) WO2008071961A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1900732A4 (en) 2005-06-24 2009-11-18 Toyama Chemical Co Ltd NOVEL HETEROCYCLIC NITROGENIC COMPOUND AND SALT THEREOF
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
US8507478B2 (en) 2008-10-10 2013-08-13 Actelion Pharmaceuticals Ltd. Oxazolidinyl antibiotics
AR076222A1 (en) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd DERIVATIVES 2-HYDROXIETIL-1H-QUINOLIN-ONA AND ITS AZAISOTHERAL ANALOGS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2813080A1 (en) * 2010-10-04 2012-04-12 British Columbia Cancer Agency Branch Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
EP3672960A2 (en) * 2017-08-21 2020-07-01 Acadia Pharmaceuticals Inc. Compounds, salts thereof and their use for the treatment of diseases
RS67273B1 (en) 2017-08-21 2025-10-31 Acadia Pharm Inc Compounds, salts thereof and their use for the treatment of diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601265A1 (en) * 1996-01-16 1997-07-17 Bayer Ag 2-oxo and 2-thio-1,2-dihydroquinolinyl oxazolidinones
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
JP5314244B2 (en) * 2004-10-27 2013-10-16 富山化学工業株式会社 Novel nitrogen-containing heterocyclic compounds and salts thereof
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1900732A4 (en) * 2005-06-24 2009-11-18 Toyama Chemical Co Ltd NOVEL HETEROCYCLIC NITROGENIC COMPOUND AND SALT THEREOF
SG164384A1 (en) * 2006-05-26 2010-09-29 Toyama Chemical Co Ltd Novel heterocyclic compound or salt thereof and intermediate thereof
JP2009539807A (en) * 2006-06-09 2009-11-19 グラクソ グループ リミテッド Substituted 1-methyl-1H-quinolin-2-one and 1-methyl-1H-1,5-naphthyridin-2-one as antibacterial agents
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
NZ573644A (en) * 2006-07-20 2011-09-30 Glaxo Group Ltd Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones

Also Published As

Publication number Publication date
RU2009126731A (en) 2011-01-20
EP2121702A1 (en) 2009-11-25
PE20081511A1 (en) 2008-12-12
AU2007331247B2 (en) 2011-10-20
WO2008071961A8 (en) 2009-10-22
BRPI0720236A2 (en) 2013-12-24
CO6190619A2 (en) 2010-08-19
AU2007331247A1 (en) 2008-06-19
MX2009006325A (en) 2009-07-24
TW200831517A (en) 2008-08-01
KR20090090385A (en) 2009-08-25
WO2008071961A1 (en) 2008-06-19
NO20092655L (en) 2009-09-02
UY30788A1 (en) 2008-07-31
JP2010513255A (en) 2010-04-30
AR064369A1 (en) 2009-04-01
CA2671485A1 (en) 2008-06-19
CL2007003641A1 (en) 2008-09-22

Similar Documents

Publication Publication Date Title
UY32158A (en) HETEROCICLIC DERIVATIVES AND METHODS OF USE OF THE SAME
CR11641A (en) UREA HETEROCICLICAL DERIVATIVES AND METHODS OF USE OF THE SAME-211
ECSP109903A (en) DERIVATIVES OF PIRAZINONA AND ITS USE IN THE TREATMENT OF PULMONARY DISEASES
SV2010003598A (en) TIAZOL DERIVATIVES USED AS PI 3-CINASA INHIBITORS
UY30759A1 (en) CHEMICAL COMPOUNDS
CR20140392A (en) SUBSTITUTED DIHYDROPIRAZOLONES
ECSP099750A (en) IMIDAZOQUINOLINAS WITH IMMUNOMODULATING PROPERTIES
UY31940A (en) SUBSTITUTED DERIVATIVES OF 4,5- (SUBSTITUTED-PIRIDIN-3-IL) -1-METHYL-1H-INDOL, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, POLYMORPHOS, ROTÁMEROS, PRO-DRUGS, ANANTIOMERS, HYDRATES, SOLVATOS OF THE SAME AND COMPOSITIONS
ECSP10010556A (en) PIRIDINES AND PIRAZINAS AS PI3K INHIBITORS
EA200870193A1 (en) CYTOTOXIC AGENTS, INCLUDING NEW TOMAMYCIN DERIVATIVES, AND THEIR THERAPEUTIC APPLICATION
EA201200049A1 (en) 1,3-DESIGNED DERIVATIVES OF IMIDAZOLIDIN-2-IT AS CYP 17 INHIBITORS
CL2011000917A1 (en) Thioamide derivative compounds; its methods of preparation and use of the compounds for the treatment of endoparasitic diseases.
ECSP099506A (en) DERIVATIVES OF 2-QUINOLINONA AND 2 QUINOXALINONA AND ITS USE AS ANTI BACTERIAL AGENTS
UY32315A (en) PIPERIDINE COMPOUNDS AND USES OF THE SAME-596
BRPI0507312A (en) quinoline derivatives for use as mycobacterial inhibitors
UY30544A1 (en) PIRROLO-PIPERIDINE COMPOUNDS AND PHARMACEUTICAL SALTS ACCEPTABLE OF THE SAME, MANUFACTURING PROCESSES, COMPOSITIONS AND APPLICATIONS
UY31141A1 (en) PIPERIDINE COMPOUNDS AND ITS USES
ECSP10010664A (en) HETEROCYCLIC UREA DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS
ECSP109900A (en) USEFUL PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY OR ALLERGIC CONDITIONS
UY32856A (en) UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME
UY32674A (en) UREA HETEROCICLICAL DERIVATIVES AND THEIR EMPLOYMENT METHODS
DOP2010000374A (en) UREA HETEROCICLICAL DERIVATIVES AND THEIR EMPLOYMENT METHODS
UY29170A1 (en) REPLACED ADENINS AND USES OF THE SAME
UY32694A (en) UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME
UY32316A (en) USEFUL PIPERIDINE DERIVATIVES IN THE TREATMENT OF BACTERIAL INFECTIONS